{"abstract":"The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patent Applications listed in the Supplementary Information section of this notice to Sixfold Biosciences Inc., (\"Sixfold\") of Walnut, California.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2018/12/21/2018-27671.html","cfr_references":[],"citation":"83 FR 65694","comment_url":null,"comments_close_on":"2019-01-07","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before January 7, 2019 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2018-27671","effective_on":null,"end_page":65695,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2018/12/21/2018-27671.xml","html_url":"https://www.federalregister.gov/documents/2018/12/21/2018-27671/prospective-grant-of-an-exclusive-patent-license-multifunctional-rna-nanoparticles-and-methods-of","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2018-27671?publication_date=2018-12-21","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2018-12-21/2018-27671/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":279,"last_updated":"2026-08-26 02:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2018-12-21/pdf/2018-27671.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2018-27671.pdf?1545313537","publication_date":"2018-12-21","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2018/12/21/2018-27671.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T23:31:48Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":65694,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: “Multifunctional RNA Nanoparticles and Methods of Uses” and “RNA/DNA Hybrid Nanoparticles Modified With Single Stranded RNA Toeholds and Uses Thereof”","toc_doc":"Multifunctional RNA Nanoparticles and Methods of Uses and RNA/DNA Hybrid Nanoparticles Modified with Single Stranded RNA Toeholds and Uses Thereof","toc_subject":"Prospective Grant of Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":83}